| Literature DB >> 26138798 |
George A Margaritopoulos1,2, Sergio Harari3, Antonella Caminati3, Katerina M Antoniou1.
Abstract
For many years, cigarette smoking has been considered as the leading cause of chronic obstructive pulmonary disease and lung cancer. Recently, however, it has also been associated with the development of diffuse interstitial lung diseases. In the latest classification of the major idiopathic interstitial pneumonias (IIP), the term smoking-related IIP has been introduced, including two entities, namely desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-interstitial lung disease (RB-ILD). Other entities in which smoking has a definite or suggested role include pulmonary Langerhan's cell histiocytosis, smoking-related interstitial fibrosis, combined pulmonary fibrosis and emphysema syndrome and idiopathic pulmonary fibrosis. In this review, we will focus on the mechanisms of smoking-related lung damage and on the clinical aspects of these disorders with the exception of idiopathic pulmonary fibrosis, which will be reviewed elsewhere in this review series.Entities:
Keywords: diagnosis; fibrosis; inflammation; nicotine; smoking; therapy
Mesh:
Year: 2015 PMID: 26138798 DOI: 10.1111/resp.12576
Source DB: PubMed Journal: Respirology ISSN: 1323-7799 Impact factor: 6.424